Quantitative Investment Management, LLC Supernus Pharmaceuticals, Inc. Transaction History

Quantitative Investment Management, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2020 Nov 13, 2020	SELL	$20.2 - $25.05 $475,790 - $590,027	-23,554 Closed	0 $0
Q2 2020 Aug 14, 2020	BUY	$17.09 - $24.89 $402,537 - $586,259	23,554 New	23,554 $559,000
Q3 2018 Nov 14, 2018	SELL	$42.7 - $56.55 $4.15 Million - $5.49 Million	-97,100 Closed	0 $0
Q2 2018 Aug 10, 2018	BUY	$44.1 - $59.85 $2.16 Million - $2.93 Million	48,900 Added 101.45%	97,100 $5.81 Million
Q1 2018 May 15, 2018	BUY	$37.15 - $46.9 $1.79 Million - $2.26 Million	48,200 New	48,200 $2.21 Million

290

60.7M

27.7K

11.3K

Ticker SUPN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 53,495,300
Market Cap $2.05B
Description
Supernus Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of products for the treatment of central nervous system (CNS) diseases in the United States. Its commercial products are Trokendi XR, an extended release topiramate product indicated for the treatment of epilepsy, as well as for the prop...

Get notified when there are updates to the investment portfolio of Quantitative Investment Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Quantitative Investment Management, LLC with notifications on news.